CC
ACAD icon

Centiva Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Centiva Capital’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Hold
0
– – – 1273
2025
Q3 		– Hold
0
– – – 1031
2023
Q2 		– Sell
-19,150
Closed -$360K – 1591
2023
Q1 		$360K Buy
+19,150
New +$365K 0.02% 971
2021
Q2 		– Sell
-67,674
Closed -$1.75M – 1355
2021
Q1 		$1.75M Buy
67,674
+56,992
+534% +$2.51M 0.24% 213
2020
Q4 		$571K Sell
10,682
-2,474
-19% -$123K 0.07% 414
2020
Q3 		$543K Buy
13,156
+1,662
+14% +$71.8K 0.09% 309
2020
Q2 		$557K Buy
+11,494
New +$552K 0.13% 264

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return